Mechanism of Chronic Migraine

被引:0
|
作者
Sheena K. Aurora
Arun Kulthia
Patricia M. Barrodale
机构
[1] Swedish Headache Center,
[2] Swedish Neurosciences Institute,undefined
来源
关键词
Chronic migraine; Imaging; Physiology; Mechanism;
D O I
暂无
中图分类号
学科分类号
摘要
Chronic migraine typically evolves from episodic migraine over months to years in susceptible individuals. Headaches increase in frequency over time, becoming less intense but more disabling and less responsive to treatment. Results of electrophysiologic and functional imaging studies indicate that chronic migraine is associated with abnormalities in the brainstem that may be progressive. Additionally, chronic migraine is associated with a greater degree of impairment in cortical processing of sensory stimuli than is episodic migraine, perhaps due to a more pervasive or persistent cortical hyperexcitability. These findings fit with the model of migraine as a spectrum disorder, in which the clinical and pathophysiological features of migraine may progress over time. This progression is postulated to result from changes in nociceptive thresholds and ensuing central sensitization caused by recurrent migraine in susceptible individuals, for whom a variety of risk factors have been described. This may lead to changes in baseline neurologic function between episodes of headache, evident not only in electrophysiologic and functional imaging studies, but also as an increase in depression, anxiety, nonhead pain, fatigue, gastrointestinal disorders, and other somatic complaints that may occur after years of episodic migraine. From the current research and migraine models, a conceptualization of chronic migraine, in which relatively permanent and pervasive central changes that warrant novel and tolerable treatments have occurred, is emerging. This model also implies that prevention of chronic migraine is an important goal in the management of episodic migraine, particularly in individuals who exhibit risk factors for chronic transformation.
引用
收藏
页码:57 / 63
页数:6
相关论文
共 50 条
  • [41] OnabotulinumtoxinA for Chronic Migraine
    Blumenfeld, Andrew
    Evans, Randolph W.
    HEADACHE, 2012, 52 (01): : 142 - 148
  • [42] Chronic migraine: pathophysiology
    Sanchez del Rio-Gonzalez, Margarita
    REVISTA DE NEUROLOGIA, 2012, 54 : S13 - S19
  • [43] OnabotulinumtoxinA for Chronic Migraine
    Blumenfeld, Andrew
    Evans, Randolph W.
    HEADACHE, 2017, 57 (10): : E10 - E16
  • [44] Treatment of Chronic Migraine
    Hans-Christoph Diener
    Dagny Holle
    David Dodick
    Current Pain and Headache Reports, 2011, 15 : 64 - 69
  • [45] Chronic migraine in young age: clinical characteristics in a prospective chronic migraine registry
    Ruiz, M.
    Pedraza, M. I.
    de la Cruz, C.
    Rodriguez, C.
    Hernandez, M. S.
    de Lera, M.
    Munoz, I.
    Moreno, R.
    Baron, J.
    Guerrero, A.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [46] Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies
    Aurora, Sheena K.
    Brin, Mitchell F.
    HEADACHE, 2017, 57 (01): : 109 - 125
  • [47] P042. Mechanism of action and clinical evidence of botulinum toxin in chronic migraine
    Giovanni Franco
    Eleonora Vecchio
    Marianna Delussi
    Katia Ricci
    Anna Montemurno
    Marina de Tommaso
    The Journal of Headache and Pain, 2015, 16
  • [48] Employment and Work Impact of Chronic Migraine and Episodic Migraine
    Stewart, Walter F.
    Wood, G. Craig
    Manack, Aubrey
    Varon, Sepideh F.
    Buse, Dawn C.
    Lipton, Richard B.
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2010, 52 (01) : 8 - 14
  • [49] Comparison of the headache characteristics of chronic migraine in intermittent migraine
    Couch, JR
    Stewart, K
    ANNALS OF NEUROLOGY, 2004, 56 : S6 - S6
  • [50] Chronic migraine is an earlier stage of transformed migraine in adults
    Bigal, ME
    Tepper, SJ
    Rapoport, AM
    Sheftell, FD
    Lipton, RB
    HEADACHE, 2005, 45 (06): : 769 - 770